ArticlePharmaceutics2026

Oral Rhizoma Coptis Alkaloids Nanoparticle for Treating Diabetes Through Regulating PI3K/Akt Pathways.

Yuejiao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.